R - 10

Retatrutide is a novel investigational peptide being studied as a potential multi-receptor agonist for its significant metabolic and weight-loss effects. It is designed to target the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, creating a synergistic effect that may help regulate glucose metabolism, appetite, and energy expenditure.

Retatrutide has gained attention in clinical research for its potential to manage obesity, type 2 diabetes, and other metabolic disorders. Its unique triple-receptor mechanism differentiates it from existing single-receptor GLP-1 agonists.